Norpace®
Back to Test Catalogue
Disopyramide, Serum/Plasma
Test ID: DISOP
Test
Aliases/Synonyms
Method
Immunoassay
Report Includes
Disopyramide
Specimens
Avoid gel separator tubes; Serum; Plasma (Heparin); Plasma (EDTA)
Clinical Utility
Disopyramide is useful in treating patients with cardiac arrhythmias and tachcardia. Therapeutic drug monitoring is useful to optimize dose and avoid toxicity.
Test Location
Quest Diagnostics, Virginia USA
Test Version
20-Nov-2019
Specimen
Specimens
Avoid gel separator tubes; Serum; Plasma (Heparin); Plasma (EDTA)
Collection Containers
Preferred
Serum (red top)
Acceptable
Plasma sodium heparin green top; Plasma EDTA lavender top
Sample Volume
1 mL
Minimum Volume
0.5 mL
Specimen Comment
Avoid gel separator tubes.
Collection & Handling
Handling Information
Centrifuge and immediately separate serum or plasma specimens from the cells.
Stability
| Ambient | 5 days |
|---|---|
| Refrigerated | 14 days |
| Frozen | 35 days |
Rejection Criteria
| Specimen | Gel-separator |
|---|
Test Version
20-Nov-2019
Performance / Interpretation
Method
Immunoassay
Turnaround Time
7 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Disopyramide | mg/L |
|
||
Test Location
Quest Diagnostics, Virginia USA
Test Version
20-Nov-2019
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| DISOP | 62201DISOPYRAMIDE | mg/L |
Test Version
20-Nov-2019